Drug will be launched in the UK first

Deucravacitinib demonstrated superiority to placebo and Otezla in phase III

Trial will evaluate Sativex (nabiximols) for multiple sclerosis spasticity

British drugmaker confirmed review on Sunday

Updated Date: Tue, 27 Oct 2020 00:00:00 EDT

Updated Date: Tue, 27 Oct 2020 00:00:00 EDT

Amgen’s Otezla faces a hit from Bristol’s would-be rival, but safety data will tell the full story esagonowsky […]

Inspired by a parasitic worm that digs its sharp teeth into its host’s intestines, researchers have designed tiny, […]

A hybrid implant coating made from antibacterial silver and an antibiotic will protect patients from infection in the […]

Researchers at the RIKEN Center for Biosystems Dynamics Research have developed human-skin equivalent that reproduces traction-force balance in […]